glp-1 covered by medicaid covers meds for obesity in just 13 states, analysis finds McKee's proposed FY2027 budget drops

Moreover, as these mechanisms of action may occur concurrently, it is important to investigate alterations in drug exposure when multiple mechanisms are considered simultaneously

10.1085/jgp.8.6.519 J

A method of preventing gait abnormalities in a patient with Parkinson's disease or of improving or restoring to normal the gait of a patient with Parkinson's disease, comprising the step of administering to said patient an amount of one or more hepatocyte growth factor mimics sufficient to prevent, improve or restore to normal said gait, said one or more hepatocyte growth factor mimics having a general structural formula 1 2 3 where Ri is one of an N-acyl group, a substituted or unsubstituted phenyl, a norleucine group, and an amino acid selected from tyrosine, phenylalanine, aspartic acid, arginine, isoleucine, serine, histidine, glycine, cysteine, methionine, tryptophan, lysine norvaline, ornithine, and s-benzyl cysteine

Subcutaneous injection of drugs: Literature review of factors influencing pain sensation at the injection site

Swimming duration decreased from 75.0 1.8 s in the normal control group (NaCl, 0.9%) to 15.0 1.4 s in the negative control group (KET)